ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses

Poly(ADP-ribose) polymerases participate in many biological and pathological processes. Takaoka and co-workers show that the short isoform of PARP-13 (ZAPS) is selectively induced by 5'-triphosphate–modified RNA and regulates signaling mediated by the RNA helicase RIG-I. The poly(ADP-ribose) po...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nature immunology 2011-01, Vol.12 (1), p.37-44
Hauptverfasser: Takaoka, Akinori, Hayakawa, Sumio, Shiratori, Souichi, Yamato, Hiroaki, Kameyama, Takeshi, Kitatsuji, Chihiro, Kashigi, Fumi, Goto, Showhey, Kameoka, Shoichiro, Fujikura, Daisuke, Yamada, Taisho, Mizutani, Tatsuaki, Kazumata, Mika, Sato, Maiko, Tanaka, Junji, Asaka, Masahiro, Ohba, Yusuke, Miyazaki, Tadaaki, Imamura, Masahiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Poly(ADP-ribose) polymerases participate in many biological and pathological processes. Takaoka and co-workers show that the short isoform of PARP-13 (ZAPS) is selectively induced by 5'-triphosphate–modified RNA and regulates signaling mediated by the RNA helicase RIG-I. The poly(ADP-ribose) polymerases (PARPs) participate in many biological and pathological processes. Here we report that the PARP-13 shorter isoform (ZAPS), rather than the full-length protein (ZAP), was selectively induced by 5′-triphosphate–modified RNA (3pRNA) and functioned as a potent stimulator of interferon responses in human cells mediated by the RNA helicase RIG-I. ZAPS associated with RIG-I to promote the oligomerization and ATPase activity of RIG-I, which led to robust activation of IRF3 and NF-κB transcription factors. Disruption of the gene encoding ZAPS resulted in impaired induction of interferon-α (IFN-α), IFN-β and other cytokines after viral infection. These results indicate that ZAPS is a key regulator of RIG-I signaling during the innate antiviral immune response, which suggests its possible use as a therapeutic target for viral control.
ISSN:1529-2908
1529-2916
DOI:10.1038/ni.1963